Aberrant methylation of the HRPT2 gene in parathyroid carcinoma

Annals of Otology, Rhinology and Laryngology

Volumn 116, Issue 12, 2007, Pages 928-933

  Hewitt, Kimberly M ^a   Sharma, Pramod K ^a   Samowitz, Wade ^a   Hobbs, Maurine ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

HRPT2 gene; Methylation; Parathyroid carcinoma

Indexed keywords

PARAFFIN;

ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; GENE; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENE SEQUENCE; HRPT2 GENE; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; JAW TUMOR; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MOLECULAR CLONING; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

EID: 37349099468     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940711601210     Document Type: Article

References (22)

1. Marx SJ, Simonds WF, Agarwal SK, et al. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 2002;17(suppl 2):N37-N43.
2. Jackson CE, Norum RA, Boyd SB, et al. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 1990;108:1006-13.
3. Bradley KJ, Hobbs MR, Buley ID, et al. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 2005;257:18-26.
4. Szabo J, Heath B, Hill VM, et al. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome Iq21-q31. Am J Hum Genet 1995;56:944-50.
5. Carpten JD, Robbins CM, Villablanca A, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002;32:676-80.
6. Howell VM, Haven CJ, Kahnoski K, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 2003;40:657-63. [Erratum in J Med Genet 2004;41:20.]
7. Shattuck TM, Valimaki S, Obara T, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003;349:1722-9.
8. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
9. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000;26:16-7.
10. Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T, Matsumura T. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer 2001;93:667-73.
11. Yuan J, Luo RZ, Fujii S, et al. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 2003;63:4174-80.
12. Eckhardt F, Lewin J, Cortese R, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006;38:1378-85.
13. Simonds WF, James-Newton LA, Agarwal SK, et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 2002;81:1-26.
14. Cetani F, Pardi E, Giovannetti A, et al. Genetic analysis of the MEN1 gene and HRPT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 2002;56:457-64.
15. Mallette LE, Malini S, Rappaport MP, Kirkland JL. Familial cystic parathyroid adenomatosis. Ann Intern Med 1987;107:54-60.
16. Kammori M, Nakamura K, Kanauchi H, et al. Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report. World J Surg 2002;26:1083-7.
17. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) 1992;71:197-205.
18. Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 1973;31:600-5.
19. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the US between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1999;86:538-44.
20. Tan MH, Morrison C, Wang P, et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 2004;10:6629-37.
21. Fraga MF, Esteller M. DNA methylation: a profile of methods and applications. Biotechniques 2002;33:632, 634, 636-49.
22. Pimenta FJ, Gontijo Silveira LF, Tavares GC, et al. HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol 2006;42:735-9.